Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1975-06-23
1977-01-25
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
A61K 3702
Patent
active
040051943
ABSTRACT:
A series of nonapeptide amides has been found which, upon administration at daily doses of from about 1-500 .mu.g/kg to male warm-blooded animals, cause regression and subsequent elimination of prostatic hyperplasia without causing adverse effects to healthy tissues.
REFERENCES:
the Merck Manual, 12th Ed., 1972, pp. 669-672.
Abbott Laboratories
Burgauer Paul D.
Goldberg Jerome D.
Niblack Robert L.
LandOfFree
Treatment of prostatic hyperplasia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of prostatic hyperplasia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of prostatic hyperplasia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1479102